Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease

AIM: To evaluate the clinical utility of serum fibrosis markers, including YKL-40, in patients with HCV-associated liver disease. METHODS: A total of 109 patients with HCV-associated liver disease were enrolled. We measured serum type IV collagen, amino-terminal peptide of type III procollagen (PIII...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Saitou, Yukiko, Shiraki, Katsuya, Yamanaka, Yutaka, Yamaguchi, Yumi, Kawakita, Tomoyuki, Yamamoto, Norihiko, Sugimoto, Kazushi, Murata, Kazumoto, Nakano, Takeshi
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2005
Assuntos:
Viral Hepatitis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4250794/
https://ncbi.nlm.nih.gov/pubmed/15641129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v11.i4.476
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados